Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Inclusion Criteria

Inclusion Criteria

Concurrent Medication:

Allowed:

- Topical antifungal therapy.

Patient must have:

- Newly diagnosed clinical and histological hairy leukoplakia.

- Positive HIV antibody by licensed ELISA or Western blot.

Exclusion Criteria

Co-existing Condition:

Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.

Concurrent Medication:

Excluded within 2 weeks of study entry:

- Systemic antifungal treatment.

- Excluded within 6 weeks of study entry:

- Immunomodulators.

- Systemic antiviral treatment.

Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.

Prior Medication:

Excluded within 2 weeks of study entry:

- Systemic antifungal.

- Excluded within 6 weeks of study entry:

- Immunomodulators.

- Systemic antiviral treatment.

- Excluded within 8 weeks of study entry:

- Zidovudine (AZT) or other antiretroviral therapy.